In re Maximo M.

186 Misc. 2d 266, 710 N.Y.S.2d 864, 2000 N.Y. Misc. LEXIS 273
CourtNew York City Family Court
DecidedJune 24, 2000
StatusPublished
Cited by4 cases

This text of 186 Misc. 2d 266 (In re Maximo M.) is published on Counsel Stack Legal Research, covering New York City Family Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Maximo M., 186 Misc. 2d 266, 710 N.Y.S.2d 864, 2000 N.Y. Misc. LEXIS 273 (N.Y. Super. Ct. 2000).

Opinion

OPINION OF THE COURT

Lee H. Elkins, J.

The Commissioner of the Administration for Children’s Services of the City of New York (ACS) brings this motion, by order to show cause,1 to enforce a subpoena compelling the disclosure of records regarding the respondent’s treatment for drug abuse by Addiction Research and Treatment Corporation (ARTC). ARTC is a licensed provider of out-patient medical, psychiatric, substance and alcohol abuse counseling and family development services. ACS seeks leave to subpoena said records and testimony of respondent’s treatment providers, if necessary, for use at fact finding in a child neglect proceeding pending before this court. ARTC opposes the release of this information under relevant Federal and State statutes which provide for the confidentiality of a patient’s substance abuse and clinical records.

The motion presents several issues. Initially the court must consider whether Federal or State laws absolutely prohibit disclosure of such records. If disclosure is permitted, the court must consider the standard to be applied in determining what information may be disclosed. Finally, the court must determine what procedure to use to apply the standard in a particular case.

Federal Law

The Drug Abuse Prevention, Treatment and Rehabilitation Act protects the confidentiality of a patient’s records and communications at facilities which receive Federal assistance. (42 USC § 290dd-2.)2 Assuming an individual qualifies as a “patient,” the facility in question is indeed a “drug treatment facility,” and the patient was there for purposes of “diagnosis and treatment,” his or her records are deemed confidential under 42 USC § 290dd-2.3

Notwithstanding this confidentiality, the statute permits disclosure of such records

[268]*268“[wjhether or not the patient * * * gives written consent * * *
“[i]f authorized by an appropriate order of a court of competent jurisdiction granted after application showing good cause.” (42 USC § 290dd-2 [b] [2] [C].)

The statute requires the court, “[i]n assessing good cause * * * [to] weigh the public interest and the need for disclosure against the injury to the patient, to the physician-patient relationship, and to the treatment services.” (42 USC § 290dd-2 [b] [2] [C].)

The implementing Federal regulations, 42 CFR 2.64 (d),4 also specify the factors which the court must consider in assessing good cause. The regulations permit such records and confidential communications to be disclosed where the informa[269]*269tion is unobtainable from any other source, and there is a compelling public interest which outweighs any potential injury to the patient, to the physician-patient relationship, to the treatment services, or to the rehabilitation of other patients. The implementing regulations also expressly permit disclosure of confidential communications in circumstances that constitute suspected child abuse and neglect. (42 CFR 2.63 [a] [1], [2] .)* ***5

Good cause for disclosure has been found under the Federal statutory standards in the context of a child protective proceeding. In Matter of Doe Children (93 Misc 2d 479 [Fam Ct, Queens County 1978]), the court found that the public interest in protecting children from abuse or neglect in a proceeding under article 10 of the Family Court Act is sufficient to override the privilege of confidentiality of drug treatment records. The court held that these records may be disclosed, and that the patient’s counselor may be required to give testimony. The court, in assessing the public interest involved, noted the legislative mandate in section 1011 of the Family Court Act to “help protect children from injury or mistreatment and to help safeguard their physical, mental, and emotional well-being.” In weighing the competing interests at stake the court found that:

[270]*270“The purpose of the child protective proceeding is ‘to help protect children from injury or mistreatment and to help safeguard their physical, mental, and emotional well-being.’ * * * This court is of the opinion that the interest of these young children in living in secure surroundings outweighs any possible injury to the patient, or to the physician-patient relationship. The private nature of a Family Court proceeding, and the fact that ‘[t]he records of any proceeding in the family court shall not be open to indiscriminate public inspection’ (Family Ct Act, § 166) minimizes the likelihood of the respondent’s status becoming a matter of public record. Thus, this court finds that there is good cause for disclosure of the requested records, as required by [21 USC § 1175].” (93 Misc 2d, at 481.)

The court further found support for this waiver of confidentiality in section 1046 of the Family Court Act, which abolishes the physician-patient privilege in child protective proceedings. (Matter of Doe Children, 93 Misc 2d, supra, at 481.) The court interpreted this exception to the standard evidentiary privilege as a legislative determination to “give greater protection to the interests of allegedly neglected children than to the interest of the patient in confidentiality.” (Supra, at 481.)

Support for the disclosure of such records in child protective proceedings also can be found in Matter of Lameek L. (226 AD2d 464 [2d Dept 1996]). There, the Appellate Division held that it was not error for the Family Court, in a termination of parental rights proceeding, to allow into evidence a mother’s drug treatment records where the court had determined that the mother’s drug use was the primary obstacle to reunification of the family.

State Law

New York State also affords confidentiality to substance abuse records, but does permit disclosure in limited circumstances. The relevant statute, Mental Hygiene Law § 22.05,6 states:

[271]*271“(b) All records of identity, diagnosis, prognosis, or treatment in connection with a person’s receipt of chemical dependence services shall be confidential and shall be released only in accordance with applicable provisions of the public health law, any other state law, federal law and duly executed court orders.”

This statute allows the release of substance abuse treatment records in compliance with applicable Federal law, unless another State law would prohibit disclosure. The only other relevant New York State law is Mental Hygiene Law § 33.13, which pertains to clinical records in general and allows for the release of a patient’s records where the “interests of justice significantly outweigh the need for confidentiality.” (Mental Hygiene Law § 33.13 [c] [1].) Courts applying this statute have adopted an analysis similar to the analysis of Federal law used by the court in Matter of Doe Children (supra).

For example, in Matter of City of New York v Bleuler Psychotherapy Ctr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Adoption of Virgil.
102 N.E.3d 1009 (Massachusetts Appeals Court, 2018)
In re Arthur S.
68 A.D.3d 1123 (Appellate Division of the Supreme Court of New York, 2009)
In re Keira O.
44 A.D.3d 668 (Appellate Division of the Supreme Court of New York, 2007)
In re Marlene D.
285 A.D.2d 462 (Appellate Division of the Supreme Court of New York, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
186 Misc. 2d 266, 710 N.Y.S.2d 864, 2000 N.Y. Misc. LEXIS 273, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-maximo-m-nycfamct-2000.